Gilead Sciences (GILD): analysis and statistics
Return, volatility, Sharpe ratio and risk for Gilead Sciences, a component of both the S&P 500 and the Nasdaq 100 in the Health Care. Data as of 2026-10-29.
| Last close price | $159.20 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +31.63% |
| Total return over period | +127.10% |
| Annualized volatility | 26.40% |
| Period volatility | 45.60% |
| Period T-bill | 12.40% |
| Sharpe ratio | 2.52 |
| Sortino ratio | 3.86 |
| Max drawdown | -26.59% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.30% |
| Correlation with the S&P 500 | 0.19 |
| Period range | $59.16 – $159.20 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Gilead Sciences (GILD) has posted an annualized return of +31.63% with annual volatility of 26.40%, a Sharpe ratio of 2.52. Its worst stretch (max drawdown from a peak) was -26.59%. Its correlation with the S&P 500 is 0.19, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how GILD would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with GILD →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Gilead Sciences (GILD) is of both the S&P 500 and the Nasdaq 100.
What is the Sharpe ratio? · How to optimize an investment portfolio